Zika virus news, resources and funding for global health researchers
Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes species mosquitoes. Zika can be passed from a pregnant woman to her fetus. Infection during pregnancy can cause certain birth defects. There is no vaccine or medicine for Zika. Local mosquito-borne Zika virus transmission has been reported in the continental U.S. The
CDC provides information on Zika for pregnant women, women trying to become pregnant, community health workers, policymakers and other key groups.
At NIH, the National Institute of Allergy and Infectious Diseases (NIAID) is working with its partners in government, academia, and the pharmaceutical and biotechnology industries to
better understand Zika virus, the disease it causes, and ways to combat it. Vaccinations have begun in a
multi-site clinical trial testing an experimental Zika vaccine developed by NIAID scientists. The National Institute of Child Health and Human Development (NICHD) at NIH is studying how
Zika virus infection affects reproductive health, pregnancy, and the developing fetus. NIH is also
funding many research projects to study Zika virus.
Fogarty has provided training for researchers in countries impacted by Zika, and has supported mathematical modeling to inform policymakers. While
studying Chagas disease in Brazil, funding from the National Institute of Neurological Disorders and Stroke (NINDS) through Fogarty provided scientists with training in field epidemiology, neuroimaging techniques and other research skills, which they are now leveraging to study and combat Zika. Researchers supported in part by Fogarty had
anticipated the international spread of Zika virus from Brazil due to the August 2016 summer Olympic Games.
Top News
- Human footprint is associated with shifts in the assemblages of major vector-borne diseases, co-authored by Fogarty grantees Caroline K. Glidden, Andrew J. MacDonald, and Erin A. Mordecai
Nature Sustainability, March 13, 2023
-
Profile: Fogarty Fellow Dr Leah Katzelnick investigates Zika and dengue viruses in South America
May / Jun 2021 Global Health Matters
-
NIH-developed Zika vaccine improves fetal outcomes in animal model
NIAID/NIH media advisory, December 19, 2019
-
A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern [Open access], co-authored by Fogarty's Dr Cecile Viboud
PLOS Neglected Tropical Diseases, October 4, 2019
-
Tracing Zika's genetic history
NIAID Now blog, August 28, 2019 -
Dengue immunity may be protective against symptomatic Zika, study finds
NIAID/NIH news, January 22, 2019 -
Gene variations linked to severity of Zika-related birth defects, small NIH study suggests
NICHD/NIH news, September 17, 2018
-
Zika infection during pregnancy may disrupt fetal oxygen supply
NICHD/NIH news, January 18, 2018 -
Zika remains a research and public health challenge, say NIAID scientists
NIAID/NIH news, December 21, 2017 -
Gene-based Zika vaccine is safe and immunogenic in healthy adults
NIAID/NIH news, December 4, 2017 -
Trials show inactivated Zika virus vaccine is safe and immunogenic, results support further clinical development
NIAID/NIH news, December 4, 2017
- Report:
Pregnant Women and the Zika Virus Vaccine Research Agenda: Ethics Guidance on Priorities, Inclusion, and Evidence Generation
Pregnancy Research Ethics for Vaccines, Epidemics and New Technologies (PREVENT) project, June 2017 -
Zika vaccine trial site in Peru led by Fogarty trainee
May / Jun 2017
Global Health Matters -
Fogarty-supported Chagas, dengue researchers redirect efforts to tackle Zika virus
May / Jun 2017
Global Health Matters - New resource for healthcare professionals and patients:
Zika Care Connect (ZCC)
Developed and funded by the Centers for Disease Control and Prevention (CDC), hosted and maintained by the March of Dimes -
Phase 2 Zika vaccine trial begins in U.S., Central and South America
NIAID/NIH news, March 31, 2017 -
NIH begins study of vaccine to protect against mosquito-borne diseases
NIAID/NIH news, February 21, 2017
-
Chagas disease studies inform Zika research in Brazil
Nov / Dec 2016
Global Health Matters -
NIH gathers experts to discuss Zika and child development
Nov / Dec 2016
Global Health Matters -
Testing of investigational inactivated Zika vaccine in humans begins
NIAID/NIH news, November 7, 2016
- CDC reports urine testing for Zika might be more accurate than blood analysis:
Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease - Florida, 2016
CDC Morbidity and Mortality Weekly Report (MMWR), May 13, 2016 -
Zika ethics consultation: Ethics guidance on key issues raised by the outbreak
PAHO, published May 2016
-
Mapping global environmental suitability for Zika virus
eLife, April 19, 2016
-
Scientists determine exact structure of Zika, findings could help lead to vaccine, cure, with NIAID support
Science, March 31, 2016 -
NIH-funded scientists develop mouse model for Zika:
Journal article: Characterization of a Novel Murine Model to Study Zika Virus
American Journal of Tropical Medicine and Hygiene, March 28, 2016 (online)
-
PAHO's Dr Marcos Espinal on global partnerships to fight Zika, Ebola and other diseases
Mar / Apr 2016
Global Health Matters -
Global scientific community commits to sharing data on Zika
Wellcome Trust news, February 10, 2016 - Publication resources for researchers:
NIH News and Resources
Other US Government Resources
Other Online Resources
To view Adobe PDF files, download current, free accessible plug-ins from Adobe's website.
Updated March 14, 2023